Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators. Engstrøm T, et al. Among authors: tilsted hh. Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1. Lancet. 2015. PMID: 26347918 Clinical Trial.
The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial.
Eskola MJ, Holmvang L, Nikus KC, Sclarovsky S, Tilsted HH, Huhtala H, Niemelä KO, Clemmensen P. Eskola MJ, et al. Among authors: tilsted hh. Eur Heart J. 2007 Dec;28(24):2985-91. doi: 10.1093/eurheartj/ehm428. Epub 2007 Oct 11. Eur Heart J. 2007. PMID: 17932102 Clinical Trial.
Value of the 12-lead electrocardiogram to define the level of obstruction in acute anterior wall myocardial infarction: correlation to coronary angiography and clinical outcome in the DANAMI-2 trial.
Eskola MJ, Nikus KC, Holmvang L, Sclarovsky S, Tilsted HH, Huhtala H, Niemelä KO, Clemmensen P. Eskola MJ, et al. Among authors: tilsted hh. Int J Cardiol. 2009 Jan 24;131(3):378-83. doi: 10.1016/j.ijcard.2007.10.035. Epub 2008 Jan 8. Int J Cardiol. 2009. PMID: 18191483 Clinical Trial.
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group. Rasmussen K, et al. Among authors: tilsted hh. Lancet. 2010 Mar 27;375(9720):1090-9. doi: 10.1016/S0140-6736(10)60208-5. Epub 2010 Mar 16. Lancet. 2010. PMID: 20231034 Clinical Trial.
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S. Kaltoft A, et al. Among authors: tilsted hh. J Am Coll Cardiol. 2010 Aug 17;56(8):641-5. doi: 10.1016/j.jacc.2010.05.009. J Am Coll Cardiol. 2010. PMID: 20688033 Free article. Clinical Trial.
Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction.
Tahvanainen M, Nikus KC, Holmvang L, Clemmensen P, Sclarovsky S, Birnbaum Y, Kelbæk H, Huhtala H, Tilsted HH, Eskola MJ. Tahvanainen M, et al. Among authors: tilsted hh. J Electrocardiol. 2011 Sep-Oct;44(5):495-501. doi: 10.1016/j.jelectrocard.2011.04.005. Epub 2011 Jun 21. J Electrocardiol. 2011. PMID: 21696754 Clinical Trial.
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
Jensen LO, Maeng M, Thayssen P, Villadsen A, Krusell L, Botker HE, Pedersen KE, Aaroe J, Christiansen EH, Vesterlund T, Hansen KN, Ravkilde J, Tilsted HH, Lassen JF, Thuesen L. Jensen LO, et al. Among authors: tilsted hh. EuroIntervention. 2011 Jul;7(3):323-31. doi: 10.4244/EIJV7I3A56. EuroIntervention. 2011. PMID: 21729834 Free article. Clinical Trial.
114 results